Arginine Vasopressin vs GPE

Head-to-head comparison of Arginine Vasopressin (8-Arginine Vasopressin) and GPE (Glycyl-L-prolyl-L-glutamic acid) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyArginine VasopressinGPE
CategoryCognitive EnhancementCognitive Enhancement
Full Name8-Arginine VasopressinGlycyl-L-prolyl-L-glutamic acid
Molecular Weight1084.23 Da301.30 Da
Half-Life10-20 minutesminutes
Amino Acids93
Typical Dose10-40 IU intranasal research range0.1-10 mg/kg preclinical
RouteIntranasal/SubcutaneousIntranasal/Intracerebroventricular
Purity≥98%≥98%
Studies Count10025
Research StatusClinicalPre-clinical

Arginine Vasopressin Benefits

  • memory consolidation
  • recall support
  • arousal-linked learning
  • social cognition

GPE Benefits

  • memory consolidation
  • neuroprotection
  • synaptic plasticity
  • learning support

Arginine Vasopressin Dosing

intranasal research dosing|10-40 IU per dose in studies|single or repeated administration

GPE Dosing

intranasal or ICV research doses|0.1-10 mg/kg preclinical range|repeat daily or intermittent protocols

Arginine Vasopressin Side Effects

  • blood pressure elevation
  • headache
  • hyponatremia

GPE Side Effects

  • limited human safety data
  • short half-life
  • local irritation with nasal delivery

Research Overview

Arginine Vasopressin

Animal and human studies indicate vasopressin can modulate hippocampal and limbic circuits involved in learning and memory. The effect size is context dependent, and results vary by dose, route, and baseline cognitive state.

GPE

Preclinical studies suggest GPE can reduce neuronal damage and support plasticity-related pathways in the brain. Research interest centers on hippocampal function, which links it to learning and memory paradigms.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Arginine Vasopressin stacks with:

gpenoopeptdesmopressin

GPE stacks with:

davunetidenoopeptarginine-vasopressin
nonapeptidememoryneuropeptidetripeptideneuroprotection